Autonomix (AMIX) Medical announced that European Patent Office, EPO, has granted Patent No. 3,697,298, titled, “Medical Device with Circuitry for Capturing and Processing Physiological Signals.” The newly issued ‘298 patent relates to use of its proprietary technology to collect and process sensing data for real-time physiological monitoring with broad application use that includes coronary artery/vagal nerve mapping, arterial/renal mapping, bladder/lower urinary tract applications, robotic prosthetics and implants, and central nervous system monitoring for neurotherapy.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMIX:
- Autonomix Medical, Inc.: Promising Developments and Strategic Advancements Support Buy Rating
- Autonomix finalizes design review of intravascular nerve sensing catheter
- Autonomix Medical Announces Warrant Exercise Offer
- Autonomix announces exercise of warrants for $2.5M gross proceeds
- Autonomix granted new U.S. patent on smart torquer device